Ghost Tree Capital as of March 31, 2023
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 54 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Reata Pharmaceuticals Cl A | 9.9 | $34M | 370k | 90.91 | |
| Sarepta Therapeutics (SRPT) | 7.5 | $26M | 185k | 137.83 | |
| Spdr Ser Tr S&p Biotech Call Option (XBI) | 6.8 | $23M | 300k | 76.21 | |
| Tg Therapeutics (TGTX) | 4.9 | $17M | 1.1M | 15.04 | |
| Apellis Pharmaceuticals (APLS) | 4.2 | $14M | 217k | 65.96 | |
| Amylyx Pharmaceuticals (AMLX) | 4.1 | $14M | 475k | 29.34 | |
| Axsome Therapeutics (AXSM) | 4.1 | $14M | 225k | 61.68 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 3.5 | $12M | 110k | 107.22 | |
| Akero Therapeutics (AKRO) | 3.1 | $11M | 275k | 38.26 | |
| Viking Therapeutics (VKTX) | 3.0 | $10M | 600k | 16.65 | |
| Vaxcyte (PCVX) | 2.5 | $8.4M | 225k | 37.48 | |
| Cti Biopharma | 2.5 | $8.4M | 2.0M | 4.20 | |
| Pfizer (PFE) | 2.4 | $8.2M | 200k | 40.80 | |
| Revance Therapeutics (RVNC) | 2.4 | $8.1M | 250k | 32.21 | |
| Johnson & Johnson (JNJ) | 2.3 | $7.8M | 50k | 155.00 | |
| Uniqure Nv SHS (QURE) | 2.2 | $7.6M | 375k | 20.14 | |
| Madrigal Pharmaceuticals (MDGL) | 2.1 | $7.3M | 30k | 242.27 | |
| Xenon Pharmaceuticals (XENE) | 2.1 | $7.2M | 200k | 35.79 | |
| Syndax Pharmaceuticals (SNDX) | 2.0 | $6.9M | 325k | 21.12 | |
| Iovance Biotherapeutics (IOVA) | 1.8 | $6.1M | 1.0M | 6.11 | |
| Astria Therapeutics (ATXS) | 1.8 | $6.0M | 450k | 13.30 | |
| Cogent Biosciences (COGT) | 1.8 | $5.9M | 550k | 10.79 | |
| Incyte Corporation (INCY) | 1.6 | $5.4M | 75k | 72.27 | |
| Amicus Therapeutics (FOLD) | 1.6 | $5.3M | 475k | 11.09 | |
| Mirati Therapeutics | 1.5 | $5.2M | 140k | 37.18 | |
| Protagonist Therapeutics (PTGX) | 1.5 | $5.2M | 225k | 23.00 | |
| 89bio Call Option (ETNB) | 1.4 | $4.6M | 300k | 15.23 | |
| Miragen Therapeutics (VRDN) | 1.3 | $4.5M | 175k | 25.44 | |
| Iveric Bio | 1.3 | $4.3M | 175k | 24.33 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 1.2 | $4.2M | 195k | 21.39 | |
| Aerovate Therapeutics (AVTE) | 1.2 | $4.0M | 200k | 20.17 | |
| Biomea Fusion (BMEA) | 1.1 | $3.7M | 120k | 31.01 | |
| Aclaris Therapeutics (ACRS) | 1.0 | $3.4M | 425k | 8.09 | |
| Karuna Therapeutics Ord | 0.9 | $3.2M | 18k | 181.66 | |
| BioCryst Pharmaceuticals (BCRX) | 0.7 | $2.3M | 275k | 8.34 | |
| Ambrx Biopharma Sponsored Ads | 0.7 | $2.2M | 250k | 8.92 | |
| Rain Therapeutics | 0.6 | $2.2M | 250k | 8.74 | |
| Disc Medicine (IRON) | 0.6 | $2.1M | 100k | 21.19 | |
| Avidity Biosciences Ord (RNA) | 0.6 | $1.9M | 125k | 15.35 | |
| Altimmune Com New Call Option (ALT) | 0.5 | $1.7M | 400k | 4.22 | |
| Prometheus Biosciences | 0.5 | $1.6M | 15k | 107.33 | |
| Alpine Immune Sciences (ALPN) | 0.5 | $1.5M | 200k | 7.72 | |
| Arcus Biosciences Incorporated (RCUS) | 0.4 | $1.4M | 75k | 18.24 | |
| Fusion Pharmaceuticals (FUSN) | 0.4 | $1.3M | 350k | 3.77 | |
| Aadi Bioscience (AADI) | 0.3 | $1.1M | 150k | 7.24 | |
| Tarsus Pharmaceuticals (TARS) | 0.3 | $1.0M | 80k | 12.57 | |
| Geron Corporation (GERN) | 0.3 | $977k | 450k | 2.17 | |
| X4 Pharmaceuticals (XFOR) | 0.2 | $740k | 850k | 0.87 | |
| Springworks Therapeutics (SWTX) | 0.2 | $710k | 28k | 25.75 | |
| Kezar Life Sciences (KZR) | 0.2 | $548k | 175k | 3.13 | |
| Fibrogen (FGEN) | 0.1 | $494k | 27k | 18.64 | |
| ImmunoGen | 0.1 | $480k | 125k | 3.84 | |
| Bridgebio Pharma (BBIO) | 0.1 | $415k | 25k | 16.60 | |
| Vanda Pharmaceuticals (VNDA) | 0.0 | $85k | 13k | 6.80 |
